Erdheim Chester病多发骨侵犯1例

蔡震宇, 汤小东, 郭卫, 杨荣利, 王毅飞

蔡震宇, 汤小东, 郭卫, 杨荣利, 王毅飞. Erdheim Chester病多发骨侵犯1例[J]. 中国肿瘤临床, 2017, 44(13): 677-678. DOI: 10.3969/j.issn.1000-8179.2017.13.030
引用本文: 蔡震宇, 汤小东, 郭卫, 杨荣利, 王毅飞. Erdheim Chester病多发骨侵犯1例[J]. 中国肿瘤临床, 2017, 44(13): 677-678. DOI: 10.3969/j.issn.1000-8179.2017.13.030

Erdheim Chester病多发骨侵犯1例

详细信息
    作者简介:

    蔡震宇专业方向为骨与软组织肿瘤诊疗。E-mail:caizhenyu1993@163.com

    通讯作者:

    汤小东; E-mail: Tang15877@126.com

  • 图  1   全身骨显像

    Figure  1.   Whole-body bone scan

    图  2   骨梁间可见弥漫成片状分布的泡沫状组织细胞,符合富含组织细胞的肉芽肿性病变(HE×200)

    Figure  2.   There are diffuse distribution of foamy tissue cells in bone trabecula, in accordance with granulomatous lesions that are rich in tissue cells (HE×200)

    图  3   免疫组织化学显示CD68阳性,CD1a阴性(IHC×200)

    Figure  3.   The histiocytes are positive for CD68 and negative for CD1a in immunohistochemistry (IHC×200)

    CD68 (+); B. CD1a (-)

  • [1]

    Campochiaro C, Tomelleri A, Cavalli G, et al. Erdheim-Chester disease[J]. Eur J Int Med, 2015, 26(4):223-229. DOI: 10.1016/j.ejim.2015.03.004

    [2]

    Haroche J, Arnaud L, Cohen-aubart F, et al. Erdheim-Chester Disease[J]. Curr Rheumatol Rep, 2014, 16(4):412. DOI: 10.1007/s11926-014-0412-0

    [3]

    Hervier B, Arnaud L, Charlotte F, et al. Treatment of Erdheim-Chester disease with long-term high-dose interferon-alpha[J]. Semin Arthritis Rheum, 2012, 41(6):907-913. DOI: 10.1016/j.semarthrit.2011.11.004

    [4]

    Cangi MG, Biavasco R, Cavalli G, et al. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease[J]. Ann Rheum Dis, 2015, 74(8):1596-1602. DOI: 10.1136/annrheumdis-2013-204924

    [5]

    Munoz J, Janku F, Cohen PR, et al. Erdheim-Chester disease: characteristics and management[J]. Mayo Clin proc, 2014, 89(7):985-996. DOI: 10.1016/j.mayocp.2014.01.023

图(3)
计量
  • 文章访问数:  49
  • HTML全文浏览量:  13
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-01-06
  • 修回日期:  2017-04-17
  • 发布日期:  2017-07-14

目录

    /

    返回文章
    返回